Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)

China flag China · Delayed Price · Currency is CNY
8.81
+0.04 (0.46%)
Apr 29, 2026, 3:04 PM CST
-2.33%
Market Cap 8.71B
Revenue (ttm) 3.67B
Net Income (ttm) 399.54M
Shares Out 989.20M
EPS (ttm) 0.40
PE Ratio 22.03
Forward PE 18.55
Dividend 0.40 (4.56%)
Ex-Dividend Date Oct 22, 2025
Volume 7,899,211
Average Volume 12,908,306
Open 8.91
Previous Close 8.77
Day's Range 8.70 - 8.91
52-Week Range 8.58 - 11.79
Beta 0.35
RSI 41.53
Earnings Date Apr 23, 2026

About SHE:002332

Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products; and CDMO and CMO services. It also engages in medical equipment production; technical ... [Read more]

Sector Healthcare
Founded 1972
Employees 3,205
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002332
Full Company Profile

Financial Performance

In 2025, SHE:002332's revenue was 3.76 billion, a decrease of -6.04% compared to the previous year's 4.00 billion. Earnings were 449.64 million, an increase of 13.21%.

Financial Statements

News

There is no news available yet.